Intracranial Hemorrhage in a Patient Suffering from Systemic Scleroderma

Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival aft er fi rst ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. Th is review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.